ANVS Stock Performance, Insider Transaction and News

ANVS - Annovis Bio, Inc.

Market Cap	117.16M	P/E	-	EPS this Y	66.90%	Ern Qtrly Grth	-
Income	-56.2M	Forward P/E	-3.72	EPS next Y	-22.30%	50D Avg Chg	-6.00%
Sales	-	PEG	-	EPS past 5Y	-	200D Avg Chg	-9.00%
Dividend	N/A	Price/Book	5.31	EPS next 5Y	-	52W High Chg	-46.00%
Recommedations	2.00	Quick Ratio	1.35	Shares Outstanding	11.01M	52W Low Chg	28.00%
Insider Own	24.59%	ROA	-121.77%	Shares Float	8.14M	Beta	1.59
Inst Own	11.45%	ROE	-546.40%	Shares Shorted/Prior	1.45M/1.35M	Price	13.01
Gross Margin	-	Profit Margin	-	Avg. Volume	30,311	Target Price	35.40
Oper. Margin	-	Earnings Date	May 9	Volume	21,516	Change	-3.84%

Healthcare | Biotechnology | United States

About Annovis Bio, Inc.

Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration. The company's lead product candidate is Buntanetap, which has completed three Phase 1/2 clinical trials for the treatment of Alzheimer's disease (AD), Parkinson's disease, and other chronic neurodegenerative diseases. It is also developing ANVS405, which is in Phase 2 and Phase 3 efficacy studies, an intravenous drug for protecting the brain after traumatic brain injury and/or stroke; and ANVS301, which is in Phase I clinical trials, an orally administered drug to increase cognitive capability in later stages of AD and dementia. Annovis Bio, Inc. was incorporated in 2008 and is based in Malvern, Pennsylvania.

Annovis Bio, Inc. News

04/24/24	Wall Street Analysts Believe Annovis Bio (ANVS) Could Rally 197.98%: Here's is How to Trade
04/23/24	Vertex (VRTX), TreeFrog Sign Deal for Diabetes Cell Therapies
04/19/24	Vertex (VRTX) Begins Rolling NDA Filing for Acute Pain Drug
04/19/24	Bio-Path (BPTH) Rises on Upbeat Updates From Blood Cancer Study
04/18/24	DiaMedica (DMAC) Up as Stroke Study Dosing Begins Post Relaunch
04/17/24	Intra-Cellular (ITCI) Up as Depression Drug Meets Study Goals
04/16/24	Ultragenyx (RARE) Meets Efficacy Goal in Neuro Disease Study
04/16/24	Xilio's (XLO) Shares Surge 79.8% in a Month: Here's Why
04/12/24	RallyBio (RLYB) Partners With J&J & Gets $6.6M Funding, Stock Up
04/12/24	Candel (CADL) Up as Pancreatic Cancer Drug Gets Orphan Drug Tag
04/09/24	Eyenovia (EYEN) Down 18% on Disappointing Corporate Update
04/08/24	Ocugen (OCGN) Up as DSMB Allows Cohort 2 Dosing in GA Study
04/08/24	Wall Street Analysts See a 218.92% Upside in Annovis Bio (ANVS): Can the Stock Really Move This High?
04/02/24	Annovis Bio Provides Corporate Updates and Reports Fourth Quarter and Full Year 2023 Financial Results
04/01/24	Annovis Announces Publication That Supports Understanding of Buntanetap’s Mechanism of Action in Humans
03/21/24	Wall Street Analysts Think Annovis Bio (ANVS) Could Surge 211.71%: Read This Before Placing a Bet
03/20/24	Annovis Bio Provides Data Announcement Update for the Phase II/III Study of Buntanetap in Alzheimer’s Disease
03/18/24	Are Options Traders Betting on a Big Move in Annovis Bio (ANVS) Stock?
03/06/24	Sell Signal: 3 Stocks to Unload Before the Bubble Bursts
02/27/24	Annovis Bio Announces Participation in Forum Discussion at AD/PD™ 2024

ANVS Chatroom

G37X Posted - 12 seconds ago

$ANVS

fibonacci1170 Posted - 18 seconds ago

$ANVS The float is hardly 11 million shares. Tutes have no shares to buy. I see mayhem coming if buntanetap nails AD.

To_De_Moon Posted - 1 minute ago

$ANVS lets change the world, improve lifes of people suffering those diseases and make good money 🔥🤞

Alexander_Grothendieck Posted - 1 minute ago

$ANVS 40C JUL now at 6

Del_Gue Posted - 2 minutes ago

$ANVS

patternshifter Posted - 2 minutes ago

$ANVS Let's hope this works for the folks who supported this company for years w/ their investment dollars. And most importantly for those suffering from these horrible diseases and their families and friends.

Ricky82 Posted - 2 minutes ago

$ANVS beautiful

EmotionlessRobot Posted - 2 minutes ago

$ANVS Lads and ladies we're absolute flying it

BBC_ENFORCEMENT Posted - 3 minutes ago

$ANVS 💯 % 👇

WeighProtein Posted - 3 minutes ago

$ANVS twas a short stay.

cheesedonkey Posted - 4 minutes ago

$ANVS My techs just flew out the window. We're with God now.

Joeglz Posted - 5 minutes ago

$ANVS Dec. 27, its volume was 1.53m

Youngballer100 Posted - 5 minutes ago

$ANVS $SAVA people joining the fireworks or just $AVXL Lol

WeighProtein Posted - 6 minutes ago

$ANVS still holding 100%

EsquireTradingCo Posted - 6 minutes ago

$ANVS Tell me someone wasn't buying while the ELOC was being negotiated...

WolfofWoolston Posted - 6 minutes ago

$ANVS

Jjfrans Posted - 6 minutes ago

$ANVS I think somebody is telling something to someone who is telling it to someone else…

PerfectlyFine Posted - 6 minutes ago

$ANVS Volume accelerating since 2 PM. Keep is strong and confident!

To_De_Moon Posted - 7 minutes ago

$ANVS

Joeglz Posted - 7 minutes ago

$ANVS so strong

Joeglz Posted - 7 minutes ago

$ANVS unbelievable

OIIVII3G4 Posted - 8 minutes ago

$ANVS still very cheap

Kyle_99 Posted - 8 minutes ago

$ANVS if your new, you’re months late 😂

Marypennsylvanialand Posted - 9 minutes ago

$ANVS https://youtu.be/jXZcJojTucg?si=OasWRf3cfvBenPH2

Wooley21 Posted - 9 minutes ago

$ANVS This mouse completed studies, and still is thriving!!

DankeDude Posted - 10 minutes ago

$ANVS you like creaming about those puts... you'll learn a big lesson...

BayTraderZ Posted - 10 minutes ago

$ANVS

DankeDude Posted - 11 minutes ago

$ANVS as the big shorts come in the stock hits a new HOD 17.24!!! Keep buying puts 😆 🤣 😂

OptionWave1 Posted - 12 minutes ago

$INMB just about everything they are saying on the $anvs board true for Inmb. If they ramp premium, they can come for Inmune.

Wooley21 Posted - 12 minutes ago

$ANVS I thought I would pass on some Mouse Knowledge…

Analyst Ratings

HC Wainwright & Co.	Buy	Apr 2, 24
HC Wainwright & Co.	Buy	Mar 21, 24
Brookline Capital	Hold	Feb 28, 24
Canaccord Genuity	Buy	Dec 29, 23
HC Wainwright & Co.	Buy	Nov 28, 23
HC Wainwright & Co.	Buy	Nov 13, 23
Brookline Capital	Buy	Nov 10, 23
HC Wainwright & Co.	Buy	Aug 15, 23
HC Wainwright & Co.	Buy	Jun 28, 23

Insider Trades	Relationship	Date	Transactions	Cost($)	#Shares	Value($)	#Share Own	SEC Form 4
Maccecchini Maria-Luisa	President and CEO President and CEO	Feb 06	Option	0.14	52,755	7,386	1,040,489	02/08/23
Maccecchini Maria-Luisa	President and CEO President and CEO	Jan 14	Option	0.14	32,959	4,614	987,734	01/18/22